Introduction
The early cellular response to hepatic injury has been wellstudied in animal models and human disease. In CC14-induced liver injury, for example, early infiltration by mononuclear cells is followed by proliferation of mesenchymal cells, development of fibrotic septa, and ultimately formation of nodules encased by dense scar tissue (1) (2) (3) . Accumulating evidence indicates that the septal mesenchymal cells are activated lipocytes, cells which in normal liver express desmin (2) and are the primary site for storing hepatic vitamin A (4). After injury, lipocytes are the major site of extracellular matrix gene expression (5, 6) , and are thought to play a central role in formation of the hepatic scar (for review see reference 7) .
A major element of the injury response by lipocytes is their activation into myofibroblast-like cells. This phenotypic transformation has been well characterized in situ, and includes new expression of smooth muscle a actin (2) , enlargement of the secretory apparatus (8) , increased pericellular matrix (9) , and proliferation (10) . Mechanisms underlying the proliferative component of lipocytes activation have been partly elucidated using primary culture models. Cells isolated from normal rats are initially nonproliferative when grown on uncoated plastic; cell replication accompanies progressive culturing on plastic (11, 12) . Proliferation can be accelerated by exposing cells to conditioned medium from hepatic macrophages (13) ; this model is particularly relevant to the in vivo response, because, as noted, macrophage infiltration always precedes mesenchymal cell proliferation in parenchymal injury (1) .
In culture studies of lipocyte proliferation, platelet-derived growth factor (PDGF) has been identified as the principal mitogen (13, 14) . Responsiveness to PDGF requires expression of a specific dimeric transmembrane receptor (PDGFR)', which is composed of either aa, af, or fi,8 subunits (15) . Indeed, in cultured lipocytes activated by exposure to conditioned medium from macrophages, proliferation is preceded by induction of PDGF receptor protein as assayed by immunoblot (13) .
While these culture studies have suggested that PDGF receptor induction is an important component of lipocyte activation, proof has been lacking that a similar event occurs in vivo. Additionally, the cellular distribution and receptor phenotype of PDGF receptor have not been studied in normal and injured liver. Evidence from analogous models of wound healing, especially in kidney (16) and skin (17) , suggest that in vivo expression of PDGF receptor could also be an important event in hepatic injury, and, moreover, might offer a potential target for therapeutic intervention.
In this study we have characterized PDGF receptor expression in two mechanistically distinct models of liver injury in vivo, both in situ and by examining freshly isolated cell populations, and have correlated these findings with culture models of lipocyte activation. The 
PDGF receptor immunoblot
Immunoblot of lipocyte extracts was performed using a polyclonal antibody to rat /3-PDGF receptor subunit generated against a mixture of synthetic peptides of the human and mouse /3 subunit, as previously described (22). Cells were isolated from either normal or CCl4-treated animals, and maintained in suspension culture for 24 h in 20% serum (21) RNAse protection assay RNAse protection assay was performed exactly as described by Maher and McGuire (6), using 1.0 jMg of linearized plasmid template DNA to synthesize a rat specific cRNA probe. Either 0.5 jig of mRNA or 5 jig of total RNA (specified in Figure Legends) was used in the overnight hybridization with the probe (60°C). mRNA was directly isolated using Invitrogen Micro-Fast Tract' kit (Invitrogen, San Diego, CA) according to manufacturer's specifications; total RNA was extracted and purified according to Chomczynski and Sacchi (26 
Cell proliferation assay
Cells from normal rats were plated on uncoated plastic in 24-well dishes and assayed for the incorporation of [3H] thymidine exactly as described previously (11) . Data were normalized for cell number.
Results
In lipocytes from normal liver, ,/-PDGFR mRNA was undetectable. A transcript was apparent within 1 h after CCl4, which increased to maximal at 24 h (Fig. 1, A-C) ; there was a greater than 100-fold relative increase between 1 and 24 h. Receptor mRNA levels returned to normal within 12 d after a single dose.
To assess whether induction of the ,/-PDGFR was common to different forms of liver injury, we examined its expression after ligation of the common bile duct, a form of liver injury mechanistically distinct from CC14. Receptor mRNA induction was rapid (within 8 h) and sustained for at least 4 d, although to a much lesser extent than in CC14 (-5.5-fold maximal increase) (Fig. 2, A-C) .
In contrast to the / isoform, expression of a-PDGFR mRNA was apparent in lipocytes from normal liver, but was unchanged after either CC14 or bile duct ligation (Figs. 1 and 2 (Fig. 4) . This distribution corresponds to a smooth muscle-expressing activated lipocytes (2, 28, 29) and was accompanied by a marked increase in macrophage infiltration as determined by staining with the macrophage marker ED-1 (Fig. 4) . gated animals. Low levels of a-and /-PDGFR transcripts were present in cells from normal animals, but neither was induced after liver injury (Fig. 5) .
Assessment of /3-PDGFR mRNA levels under culture conditions which we have previously associated with cellular replication confirmed that a proliferative phenotype correlated with induction of receptor mRNA. Specifically, cells grown on uncoated plastic expressed receptor mRNA at 72 h after plating, coincident with onset of cellular proliferation as assessed by incorporation of [3H] thymidine (Fig. 6 ). In contrast, cells maintained in a quiescent phenotype by suspension culture remained spherical and nonproliferative, with undetectable P-PDGFR mRNA (Fig. 7) .
Discussion
In this study we demonstrate that acute liver injury in rats is accompanied by induction of /3-PDGFR mRNA and protein.
Receptor gene induction is associated with in situ cell proliferation, and is restricted to hepatic lipocytes and not sinusoidal endothelia, the other potential PDGFR-expressing cell type in liver parenchyma. We further show that ,6-PDGFR mRNA is also induced under culture conditions in which PDGF or serumdependent lipocyte proliferation occurs (8, 11, 14) . Induction of PDGF receptor has not previously been documented in liver injury in vivo, although upregulation of PDGFR appears to be a major means of amplifying the proliferative response of mesenchymal cells in several other forms of tissue injury. In particular, arterial injury (30), renal injury (22), tissue rejection (31), and synovitis (32) all are associated with in situ expression of PDGFR. In each of these tissues the 3 isoform is induced. Predominant expression of the 63 isoform is also consistent with previous observations in cultured rat lipocytes (33, 34) . In contrast to the , / subunit, expression of the a subunit mRNA is detectable in normal cells, but is not increased with injury. Although the specific band for a-PDGFR mRNA using RNAse protection was subtle, it nonetheless likely reflects a genuine signal, because we have also detected a-PDGFR mRNA in lipocytes by reverse transcriptase-polymerase chain reaction (S. Friedman, unpublished results). Despite this apparent mRNA expression, however, significant expression of functional a receptor by lipocytes is unlikely based on the lack of responsiveness of culture-activated lipocytes to PDGF AA (33, 34) . mulation of tissue mononuclear cells may be an important prerequisite. In situ studies have noted that in liver this infiltration consistently precedes the onset of mesenchymal cell proliferation (1, 3). Moreover, in our earlier study using cultured lipocytes, receptor expression was accelerated by exposure to macrophage-conditioned medium (13) . Nonetheless, results from other studies (11, 12, 35) suggest that macrophage products are not essential for induction of PDGF-mediated proliferation in cultured lipocytes, and that serum-dependent proliferation will occur once cells have spread. A similar observation has been made in smooth muscle cells (36) . The importance of cell spreading for cellular activation and /3-PDGFR induction is underscored by the lack of cell proliferation (21) or P-PDGFR gene expression in cells maintained in suspension culture, similar to an earlier report of PDGFR downregulation in cell lines during suspension (37) . We confined our experiments to time points within 2 wk after injury, because our primary interest is in mechanisms of early lipocyte activation. Accumulated evidence indicates that lipocyte activation is a complex cascade of cellular events involving alterations in both structural and regulatory genes (38) . Therapeutic efforts to control lipocyte activation will likely be most meaningful if directed towards these early changes, when activation is reversible.
While injury induced by either CCL4 or bile duct ligation was associated with P-PDGFR mRNA induction, the relative increase in gene expression in CC14 disease was more marked than in bile duct obstruction. The basis for this difference is not known, but could be related to the extent of necrosis and inflammation. Carbon tetrachloride results in extensive parenchymal injury due to membrane disruption, with a marked inflammatory response (1, 39) . In contrast, parenchymal injury and inflammation are present but more subtle in rats with bile duct obstruction (40) . On the other hand, the return to normal of g-PDGFR mRNA expression within 1 wk after a single dose of CCL is consistent with the known reversibility of this lesion in the absence of repeated dosing. Surprisingly, even after bile duct ligation, f3-PDGFR mRNA expression returned to near normal within 1 wk, even though cholestasis persists. This finding reinforces the possibility that receptor induction in the bile duct obstruction model does not result from cholestasis per se, but rather from transient mononuclear cell infiltration, which peaks 3 d after duct ligation (40) .
Despite the clear demonstration of PDGFR induction in vivo and culture by activated lipocytes, the cellular source(s) of PDGF in liver injury are not certain. Low levels of PDGF A-chain mRNA have been detected in cultured normal lipocytes when assaying large quantities of RNA (34) , and PDGF immunoreactivity has been detected in situ in clusters of mesenchymal cells and necrotic hepatocytes (41) . However, an autocrine source for bioactive PDGF is unlikely, because cultured lipocytes fail to proliferate in the absence of exogenous PDGF even when expressing PDGF receptor (13) . Other potential sources for PDGF in vivo include platelets, macrophages, and sinusoidal endothelial cells. Alternatively, PDGF-like species have recently been described which may act via binding to the PDGF receptor (42, 43) ; expression of such a molecule in liver might elude detection by current reagents used to detect native PDGF. Other mitogens apart from PDGF may also drive lipocyte proliferation in tissue injury. Epidermal growth factor (14, 44) , fibroblast growth factor (14) , and tumor necrosis factor (45) all stimulate proliferation of cultured lipocytes, although they are less potent than PDGF (14) . 
